Sol-Gel Technologies Ltd. Banner Image

Sol-Gel Technologies Ltd.

  • Ticker SLGL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Sol-Gel Technologies Ltd. Logo Image
  • 11-50 Employees
  • Based in Ness Ziona, Israel
Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing and commercializing topical dermatological drug products. Their lead product candidates, VERED for the treatment of papulopustular rosacea and TWIN and SIRS-T for the treatment of acne vulgaris (“acne”) are based upon their proprietary microencapsulation delivery system. This technology consists of microcapsulesMore made of silica. Based on their pre-clinical and clinical data, this delivery system should enable them to develop and commercialize dermatological drug products that are more effective and/or have fewer side effects than currently marketed drugs.
4.8 / 5.0 (76)

Sol-Gel Technologies Ltd. reports have an aggregate usefulness score of 4.8 based on 76 reviews.

Sol-Gel Technologies Ltd.

Most Recent Annual Report

Sol-Gel Technologies Ltd.
MOST RECENT 2023 Annual Report

Older/Archived Annual Reports

Sol-Gel Technologies Ltd. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!